Trial Profile
A Multicenter, Double-Blind, Randomized, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of Caspofungin Versus (Amphotericin B) Liposome for Injection as Empirical Therapy in Pediatric Patients With Persistent Fever and Neutropenia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 May 2022
Price :
$35
*
At a glance
- Drugs Caspofungin (Primary) ; Amphotericin B liposomal
- Indications Fever of unknown origin; Neutropenia
- Focus Adverse reactions
- Sponsors Merck Sharp & Dohme
- 09 Feb 2014 New trial record